Topic: Thrombosis

CeloNova’s nanocoated coronary stent wins FDA nod

The FDA approved CeloNova Biosciences’ nanocoated coronary stent for the treatment of obstructive coronary artery disease. The device could be an alternative for patients who are unsuitable for drug-eluting stents or long-term antiplatelet therapy.